Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

SmartRents Mixed Fourth Quarter Results and Conservative Outlook

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
GD stock news
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

SmartRent just released their financial results for the fourth quarter of 2023, and it was a bit of a mixed bag. The company reported a GAAP EPS of -$0.02, which was below what analysts were expecting by $0.01. However, their revenue came in at $60.3 million, exceeding estimates by $0.66 million. This represents a 48.7% increase in revenue compared to the previous year, but unfortunately, their earnings did not meet expectations. Looking ahead, SmartRent also provided a conservative revenue outlook for the first quarter of 2024 and the full fiscal year.

SMRT Stock Price Plummets by 7.09% on March 5: What Caused the Drop?

On March 5, 2024, SMRT stock experienced a significant drop in its price performance. The stock opened at $2.63, which was $0.26 lower than its previous close. Throughout the trading day, the price of SMRT shares continued to decrease, ending the day at $2.42. This marked a $0.21 decrease from the previous close, representing a 7.09% drop in value.

Investors and analysts may be closely monitoring SMRT’s performance to assess the reasons behind the drop in stock price on March 5. Factors such as company news, market trends, and industry developments could have contributed to the decline in value. It will be important to watch how the stock performs in the coming days to determine if this drop was a temporary fluctuation or a more sustained trend.

SMRT Stock Shows Promising Performance with Revenue Growth in 2024

On March 5, 2024, SMRT stock showed promising performances as the company reported an increase in total revenue compared to the previous year and quarter. According to data from CNN Money, SMRT’s total revenue stood at $167.82 million for the past year, marking a significant 51.69% increase from the previous year’s total revenue of $110.64 million. Additionally, the total revenue for the third quarter of the year was reported at $58.10 million, showing an 8.8% increase from the previous quarter.

Despite the positive revenue growth, SMRT reported a net income of -$96.32 million for the past year, indicating a decrease of 33.85% compared to the previous year’s net income of -$145.48 million. However, there was a slight improvement in the net income for the third quarter, which was reported at -$7.72 million, showing a 25.37% increase from the previous quarter.

Earnings per share (EPS) for SMRT also experienced some fluctuations during the period. The EPS for the past year was reported at -$0.49, reflecting a 32.68% decrease from the previous year. However, there was a positive trend in the EPS for the third quarter, which was reported at -$0.04, showing a 26.06% increase from the previous quarter.

Overall, SMRT stock showed positive performances on March 5, 2024, with an increase in total revenue and improvements in net income and EPS compared to the previous quarter. Investors may view these results as a sign of potential growth and profitability for the company in the future. However, it is essential to conduct further analysis and research before making any investment decisions based on these financial indicators.

Tags: SMRT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Luxury vacation

Navigating Financial Challenges INNOVATE Corps Q4 2023 Report

Finance_ stocks to buy

Riskified Stock Surges on Strong Q4 Earnings Future Guidance Concerns Investors

From 4G to 5G: How Airports Are Embracing Next-Generation Mobile Infrastructure

Morgan Stanley Analyst Upgrades American Airlines Group to Overweight

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com